BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29755703)

  • 1. Gut Colonization with Carbapenem-resistant Enterobacteriaceae Adversely Impacts the Outcome in Patients with Hematological Malignancies: Results of A Prospective Surveillance Study.
    Jaiswal SR; Gupta S; Kumar RS; Sherawat A; Rajoreya A; Dash SK; Bhagwati G; Chakrabarti S
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018025. PubMed ID: 29755703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of colonisation with carbapenem-resistant Enterobacteriaceae among patients admitted to Vietnamese hospitals: Risk factors and burden of disease.
    Tran DM; Larsson M; Olson L; Hoang NTB; Le NK; Khu DTK; Nguyen HD; Vu TV; Trinh TH; Le TQ; Phan PTT; Nguyen BG; Pham NH; Mai BH; Nguyen TV; Nguyen PTK; Le ND; Huynh TM; Anh Thu LT; Thanh TC; Berglund B; Nilsson LE; Bornefall E; Song LH; Hanberger H
    J Infect; 2019 Aug; 79(2):115-122. PubMed ID: 31125639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal colonization with multidrug-resistant gram-negative bacteria in patients with hematological malignancies: a prospective study.
    Kömürcü B; Tükenmez Tigen E; Toptaş T; Fıratlı Tuğlular T; Korten V
    Expert Rev Hematol; 2020 Aug; 13(8):923-927. PubMed ID: 32574123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational study on carbapenem-resistant Enterobacterales (CRE) colonisation and subsequent risk of infection in an adult intensive care unit (ICU) at a tertiary care hospital in India.
    Sharma K; Tak V; Nag VL; Bhatia PK; Kothari N
    Infect Prev Pract; 2023 Dec; 5(4):100312. PubMed ID: 37868258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Active screening of intestinal carbapenem-resistant Enterobacteriaceae in high-risk patients admitted to the hematology wards and its effect evaluation].
    Huang XL; Wu SH; Shi PF; Xu LH; Chen C; Xie YP; Gao DQ; Chen K; Tan JF; Liu LR; Xu Y; Yang F; Yu MX; Wang SY; Qian SX
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):932-936. PubMed ID: 33333697
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study.
    Tang SSL; Chee E; Teo JQ; Chlebicki MP; Kwa ALH
    Int J Antimicrob Agents; 2021 Jun; 57(6):106340. PubMed ID: 33857538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of carbapenem-resistant Enterobacteriaceae infection and colonisation: a Malaysian tertiary care hospital based case-control study.
    Chuah CH; Gani Y; Sim B; Chidambaram SK
    J R Coll Physicians Edinb; 2021 Mar; 51(1):24-30. PubMed ID: 33877130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perianal swabs surveillance cultures of Carbapenem-resistant Enterobacteriaceae(CRE) can be hints for CRE bloodstream infection in patients with hematological diseases].
    Xu CH; Su Y; Lyu YX; Tian ZY; Sun FJ; Lin QS; Wang C
    Zhonghua Xue Ye Xue Za Zhi; 2018 Dec; 39(12):1021-1025. PubMed ID: 30612405
    [No Abstract]   [Full Text] [Related]  

  • 9. Rectal Carriage of Carbapenem-Resistant Enterobacteriaceae: A Menace to Highly Vulnerable Patients.
    Kumar A; Mohapatra S; Bakhshi S; Mahapatra M; Sreenivas V; Das BK; Sood S; Kapil A
    J Glob Infect Dis; 2018; 10(4):218-221. PubMed ID: 30581264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.
    Liss BJ; Vehreschild JJ; Cornely OA; Hallek M; Fätkenheuer G; Wisplinghoff H; Seifert H; Vehreschild MJ
    Infection; 2012 Dec; 40(6):613-9. PubMed ID: 22665143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of and risk factors for carbapenem-resistant
    Barber KE; Wagner JL; Larry RC; Stover KR
    J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33263511
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical characteristics of carbapenem-resistant
    Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Seo H; Lee SC; Chung H; Ra SH; Sung H; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Chong YP
    Int J Antimicrob Agents; 2020 Oct; 56(4):106126. PubMed ID: 32755654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Dysbiosis in Carriers of Carbapenem-Resistant
    Korach-Rechtman H; Hreish M; Fried C; Gerassy-Vainberg S; Azzam ZS; Kashi Y; Berger G
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32350099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017.
    Kotb S; Lyman M; Ismail G; Abd El Fattah M; Girgis SA; Etman A; Hafez S; El-Kholy J; Zaki MES; Rashed HG; Khalil GM; Sayyouh O; Talaat M
    Antimicrob Resist Infect Control; 2020; 9(1):2. PubMed ID: 31911830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.
    McConville TH; Sullivan SB; Gomez-Simmonds A; Whittier S; Uhlemann AC
    PLoS One; 2017; 12(10):e0186195. PubMed ID: 29023567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carriage prevalence of carbapenem-resistant Enterobacteriaceae in stool samples: A surveillance study.
    Rai S; Das D; Niranjan DK; Singh NP; Kaur IR
    Australas Med J; 2014; 7(2):64-7. PubMed ID: 24611074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
    Viale P; Tumietto F; Giannella M; Bartoletti M; Tedeschi S; Ambretti S; Cristini F; Gibertoni C; Venturi S; Cavalli M; De Palma A; Puggioli MC; Mosci D; Callea E; Masina R; Moro ML; Lewis RE
    Clin Microbiol Infect; 2015 Mar; 21(3):242-7. PubMed ID: 25658534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
    Dickstein Y; Edelman R; Dror T; Hussein K; Bar-Lavie Y; Paul M
    J Hosp Infect; 2016 Sep; 94(1):54-9. PubMed ID: 27392978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.